RHUMBLINE ADVISERS - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$4,319,665
-30.5%
269,307
+0.5%
0.01%
-28.6%
Q2 2023$6,212,100
+99325.4%
267,994
-0.4%
0.01%
-12.5%
Q1 2023$6,248
+67.1%
268,974
+4.4%
0.01%
+60.0%
Q4 2022$3,739
-99.9%
257,692
+4.5%
0.01%
-28.6%
Q3 2022$4,706,000
+9.0%
246,633
+3.8%
0.01%
+16.7%
Q2 2022$4,317,000
-24.5%
237,603
+4.7%
0.01%
-14.3%
Q1 2022$5,721,000
-9.0%
227,041
-0.3%
0.01%
-12.5%
Q4 2021$6,288,000
-15.4%
227,827
-1.1%
0.01%
-20.0%
Q3 2021$7,435,000
-5.3%
230,270
-10.3%
0.01%0.0%
Q2 2021$7,847,000
-2.6%
256,602
-3.1%
0.01%
-9.1%
Q1 2021$8,060,000
+53.9%
264,701
-0.0%
0.01%
+57.1%
Q4 2020$5,237,000
+70.3%
264,811
+12.3%
0.01%
+40.0%
Q3 2020$3,076,000
+8.1%
235,910
-6.0%
0.01%0.0%
Q2 2020$2,846,000
-25.2%
250,986
-5.6%
0.01%
-37.5%
Q1 2020$3,803,000
-44.1%
265,773
+6.3%
0.01%
-27.3%
Q4 2019$6,806,000
+1.3%
249,931
+6.5%
0.01%
-8.3%
Q3 2019$6,720,000
+9.5%
234,723
+6.2%
0.01%0.0%
Q2 2019$6,139,000
-9.7%
221,004
+7.9%
0.01%
-7.7%
Q1 2019$6,802,000
+13.0%
204,889
-1.0%
0.01%0.0%
Q4 2018$6,019,000
-19.2%
207,061
+27.8%
0.01%
-7.1%
Q3 2018$7,452,000
+21.3%
161,991
-1.4%
0.01%
+16.7%
Q2 2018$6,142,000
+25.8%
164,369
-0.5%
0.01%
+20.0%
Q1 2018$4,882,000
-12.4%
165,204
+1.8%
0.01%
-9.1%
Q4 2017$5,571,000
+12.1%
162,219
+18.1%
0.01%0.0%
Q3 2017$4,970,000
+43.7%
137,380
+2.7%
0.01%
+37.5%
Q2 2017$3,458,000
+36.7%
133,805
+1.6%
0.01%
+33.3%
Q1 2017$2,530,000
+98.4%
131,758
+72.3%
0.01%
+100.0%
Q4 2016$1,275,000
-14.1%
76,457
+5.9%
0.00%
-25.0%
Q3 2016$1,485,000
-31.2%
72,174
+2.2%
0.00%
-33.3%
Q2 2016$2,160,000
-17.9%
70,590
+0.4%
0.01%
-25.0%
Q1 2016$2,632,000
-12.0%
70,320
+1.5%
0.01%
-20.0%
Q4 2015$2,991,000
+15.4%
69,310
+0.2%
0.01%
+11.1%
Q3 2015$2,592,000
+12.4%
69,160
+1.9%
0.01%
+28.6%
Q2 2015$2,306,000
-5.9%
67,856
-2.0%
0.01%0.0%
Q1 2015$2,451,000
+6.5%
69,243
+2.4%
0.01%0.0%
Q4 2014$2,302,000
-13.4%
67,593
-2.0%
0.01%
-12.5%
Q3 2014$2,659,000
-0.5%
68,948
+0.4%
0.01%0.0%
Q2 2014$2,672,000
+9.3%
68,661
-3.9%
0.01%
+14.3%
Q1 2014$2,444,000
+53.7%
71,481
-5.7%
0.01%
+40.0%
Q4 2013$1,590,000
-18.3%
75,765
-8.6%
0.01%
-16.7%
Q3 2013$1,947,000
-14.6%
82,852
-2.4%
0.01%
-14.3%
Q2 2013$2,281,00084,8960.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders